This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Ramakant Chanagare: Innovator in Respiratory Treatment
Introduction
Ramakant Chanagare is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of respiratory medicine through his innovative work on metered dose inhalers.
Latest Patents
Ramakant holds a patent for a metered dose inhaler designed for ipratropium bromide solution. This invention relates to a device that comprises a stable inhalable composition of ipratropium bromide, contained in a canister fitted with a metering valve, an actuator, and a dose indicator. The invention also includes a process for preparing this pharmaceutical composition, which is used in the treatment of respiratory disorders, particularly for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Career Highlights
Ramakant Chanagare is currently associated with Glenmark Pharmaceuticals Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in developing inhalation therapies has positioned him as a key player in respiratory health.
Collaborations
Ramakant has collaborated with notable colleagues such as Ulhas R Dhuppad and Raveendra Pai, contributing to advancements in their field.
Conclusion
Ramakant Chanagare's work exemplifies the impact of innovation in healthcare, particularly in improving treatments for respiratory conditions. His contributions are vital for patients in need of effective inhalation therapies.